Measurement of the soluble angiopoietin receptor tie-2 in patients with coronary artery disease: development and application of an immunoassay
- 19 June 2003
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 33 (7) , 529-535
- https://doi.org/10.1046/j.1365-2362.2003.01173.x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetesClinical Science, 2002
- Rescue of the early vascular defects in Tek/Tie2 null mice reveals an essential survival functionEMBO Reports, 2001
- The angiopoietin–tie2 system in coronary artery endothelium prevents oxidized low-density lipoprotein-induced apoptosisCardiovascular Research, 2001
- Early Expression of Angiogenesis Factors in Acute Myocardial Ischemia and InfarctionNew England Journal of Medicine, 2000
- Angiopoietin-1 and Its Receptor Tie-2 Participate in the Regulation of Capillary-like Tubule Formation and Survival of Endothelial CellsMicrovascular Research, 1999
- New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGFOncogene, 1999
- Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGFScience, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth.Journal of Clinical Investigation, 1997
- Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospectsJournal of Molecular Medicine, 1995